Tom Chen

Go-getter
DISC Type : d

Senior Director, Head of Drug Substance and MSAT at Dianthus Therapeutics, Inc.

Cambridge, Massachusetts, United States

Overview

Tom Chen is a seasoned leader with over 20 years of experience in drug development and protein biochemistry. As a Senior Director at Dianthus Therapeutics, he heads the Drug Substance and CMC teams for biologic products, leveraging his PhD from the Max Planck Institute.

His research publications focus on the molecular level of disease, including how certain proteins can interfere with cellular processes, which is relevant to understanding neurodegenerative disorders.

Personality Overview

Vision Oriented

Decisive

Direct & Candid

They care equally about the product and its potential impact.  They respond well to confident salespeople. They focus on objectivity in a pitch and pay little attention to bells and whistles.

Topics They Care About

Biologics Development
Leads the development of biologics, including monoclonal antibodies, bispecifics, and fusion proteins at Dianthus Therapeutics.
CMC Strategy
He is responsible for designing and executing phase-appropriate CMC strategies for pipeline molecules, a key part of his leadership role.
Protein Biochemistry
His PhD and over two decades of experience are in this field. His publications delve into protein quality control and chaperone functions.

Media Appearances

Tom has no verified media appearances

Work History

12-2024
Senior Director, Head of Drug Substance and MSAT at Dianthus Therapeutics, Inc.
5-2022 - 12-2024
Director, Drug Substance and Early Development CMC Lead at Dianthus Therapeutics, Inc.
2021 - 4-2022
Director, Analytical and Formulation Development - CMC Lead at Dianthus Therapeutics, Inc.
2021 - 2021
Director, Analytical and Pharmaceutical Science at Eagle Pharmaceuticals, Inc.
2019 - 2021
Associate Director of Analytical Development at STC Biologics Inc

Education

Ph from Max Planck Society
PhD from Ludwig-Maximilians-Universität München

More Information

Social Presence :

Prographics :

Exp : 15 Location : Cambridge, Massachusetts, United States Job Level : Senior Designation : Senior Director, Head of Drug Substance and MSAT at Dianthus Therapeutics, Inc.
URL has been copied!

Insights For Selling To Tom

During A Call Or A Meeting

DO's

  • Be crisp while making the pitch
  • Ask them questions confidently while doing discovery, don’t be apologetic
  • Make sure that they have the necessary authority, they could present false stature sometimes

DONT's

  • Don’t try to be an alpha salesperson, give them equal space
  • Avoid long winding pitches, stay objective
  • Do not give up if they are not convinced, try again with a different approach

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Tom is

  • Confidence in the product plays an important role, followed by powerful testimonials.
  • Will you ever get a clear answer from Tom

  • They might hesitate a little, but they will say no if they are not convinced.

Insights For Deal Planning

    How fast (or slow) will Tom move?

  • Their decision making speed is somewhere in the middle.
  • Can Tom take some risk or not?

  • Once they have analyzed the pros and cons, they can take some risks.

You And Tom

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.